AFSTYLA®, for Haemophilia A, Receives European Commission Approval
Go back to AFSTYLA®, for Haemophilia A, Receives European Commission Approval| CARLISLE COMPANIES, Inc. (NYSE: CSL) | Delayed: 353.01 -3.52 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $356.53 | 52 Week High | $114.49 | |||
| Open | $352.50 | 52 Week Low | $75.17 | |||
| Day High | $355.30 | P/E | 97.79 | |||
| Day Low | $348.91 | EPS | $3.61 | |||
| Volume | 150,590 | |||||
| (AMEX: CSLLY) | Delayed: 30.60 -0.32 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.92 | 52 Week High | $45.60 | |||
| Open | $30.69 | 52 Week Low | $33.39 | |||
| Day High | $30.79 | P/E | N/A | |||
| Day Low | $30.60 | EPS | $0.00 | |||
| Volume | 137,984 | |||||
